International drug control: Consensus fractured

International Drug Control: Consensus Fractured

Volumn 9781107014978, Issue , 2009, Pages 1-344

  Bewley Taylor, David R ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924482525     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139057424     Document Type: Book

References (438)

1. UNODC, World Drug Report 2010 (New York: United Nations, 2010), p. 31.
2. UN, Special Session of the General Assembly Devoted to Countering the World Drug Problem Together, 8-10 June 1998, Political Declaration, Guiding Principles of Drug Demand Reduction and Measures to Enhance International Cooperation to Counter the World Drug Problem (Vienna: United Nations, 1999), pp. 5-6.
3. C. D. Kaplan, ‘The Uneasy Consensus: Prohibitionist and Experimentalist Expectancies Behind the International Narcotics Control System’, Tijdschrift voor Criminologie, 26 (1984), 105.
4. N. Boister, Penal Aspects of the UN Drug Conventions (The Hague: Kluwer International, 2001), p. 2.
5. S. D. Krasner, ‘Structural Causes and Regime Consequences: Regimes as Intervening Variables’, International Organization, 32 (2) (1982), 185.
6. P. Andreas and E. Nadelmann, Policing the Globe: Criminalization and Crime Control in International Relations (New York: Oxford University Press, 2006), p. 38.
7. H. L. May, ‘Narcotic Drug Control - Development of International Action and the Establishment of Supervision Under the United Nations’, International Conciliation, 441 (1948), 305.
8. C. Carstairs, ‘The Stages of the International Drug Control System’, Drugs and Alcohol Review, 24 (2005), 61.
9. D. Bewley-Taylor and M. Jelsma, Fifty Years of the 1961 Single Convention on Narcotic Drugs: A Reinterpretation (Amsterdam: Transnational Institute, Series on Legislative Reform of Drug Policies, Nr. 12, 2011).
10. S. D. Krasner, ‘Structural Causes and Regime Consequences: Regimes as Intervening Variables’, in S. D. Krasner (ed.), International Regimes (Ithaca, New York: Cornell University Press, 1983), p. 2.
11. F. Kratochwil, ‘The Force of Prescriptions’, International Organization, 38, 4 (1984), 686.
12. A. Florini, ‘The Evolution of International Norms’, International Studies Quarterly, 40, 3 (1996), 364-5.
13. J. G. March and J. P. Olsen, Rediscovering Institutions: The Organizational Basis of Politics (New York: Free Press, 1989), p. 23.
14. K. Krajewski, ‘How Flexible are the United Nations Drug Conventions?’ International Journal of Drug Policy, 10, 6 (1999), 329-38.
15. M. Akehurst, A Modern Introduction to International Law (London: George Allen and Unwin, 1982), p. 164.
16. A. Aust, Modern Treaty Law and Practice (Cambridge University Press, 2007), p. 230.
17. N. Dorn and A. Jamieson, Room for Manoeuvre; Overview of Comparative Legal Research into National Drug Laws of France, Italy, Spain, the Netherlands and Sweden and their Relation to Three International Drug Conventions (London: DrugScope, 2000).
18. H. G. Levine, ‘Global Drug Prohibition: Its Uses and Crises’, International Journal of Drug Policy, 14, 2 (2003), 150.
19. E. Bertram, M. Blachman, K. Sharpe and P. Andreas, Drug War Politics: The Price of Denial (University of California Press, 1996), p. 26.
20. R. O. Keohane, ‘The Analysis of International Regimes: Towards a European-American Research Programme’, in V. Rittberger (ed.), Regime Theory and International Relations (Oxford: Clarendon Press, 1995), p. 43.
21. H. W. Brands, What America Owes the World; The Struggle for the Soul of Foreign Policy (Cambridge University Press, 1998), p. vii.
22. D. R. Bewley-Taylor, The United States and International Drug Control, 1909-1997 (London: Continuum, 2001).
23. J. Gerber and E. L. Jensen (eds.), Drug War American Style: The Internationalization of Failed Policy and Its Alternatives (New York: Garland Publishing, 2001).
24. W. B. McAllister, Drug Diplomacy in the Twentieth Century: An International History (London: Routledge, 2000).
25. K. Bruun, L. Pan and I. Rexed, The Gentlemen’s Club: International Control of Drugs and Alcohol (Chicago: University of Chicago Press, 1975), pp. 132-49.
26. J. Buxton, ‘The Historical Foundations of the Narcotic Drug Control Regime’, in P. Keefer and N. Loayza (eds.), Innocent Bystanders: Developing Countries and the War on Drugs (Basingstoke, UK: Palgrave Macmillan/Washington: The World Bank, 2010), pp. 61-93.
27. J. Sinha, The History and Development of the Leading International Drug Control Conventions (Report Prepared for the Canadian Senate Special Committee on Illegal Drugs, 2001).
28. C. S. J. Fazey, ‘The Commission on Narcotic Drugs and the United Nations International Drug Control Programme: Politics, Policies and Prospects for Change’, International Journal of Drug Policy, 14, 2 (2003), 165.
29. F. Thoumi, ‘Can the United Nations Support “Objective” and Unhampered Illicit Drug Policy Research?’ Crime, Law and Social Change, 38, 2 (2002), 177-9.
30. F. Thoumi, ‘Can the United Nations Support “Objective” and Unhampered Illicit Drug Policy Research?’ Crime, Law and Social Change, 38, 2 (2002), 177-9.
31. A. Hasenclever, P. Mayer and V. Rittberger, ‘Does Regime Robustness Require a Fair Distribution of the Gains From Cooperation: An Essay on the Methodology of Necessary Conditions as Applied to a Substantive Hypothesis Concerning the “Staying Power” of International Regimes’, in A. Underdal and O. R. Young (eds.), Regime Consequences: Methodological Challenges and Research Strategies (Dordrecht: Kluwer Academic Publishers, 2004), p. 193.
32. A. Hasenclever, P. Mayer and V. Rittberger, Theories of International Regimes (Cambridge University Press, 1997), p. 2.
33. H. Breitmeier, O. R. Young and M. Zürn, Analyzing International Environmental Regimes: From Case Study to Data Base (Cambridge, Massachusetts: The MIT Press, 2006), p. 2-7.
34. J. Buxton, The Political Economy of Narcotics: Production, Consumption and Global Markets (London: Zed Books, 2006), p. 85.
35. E. Nadelmann, ‘Global Prohibition Regimes: The Evolution of Norms in International Society’, International Organization, 44, 4 (1990), 512.
36. P. Reuter and F. Trautmann, A Report on Global Illicit Drugs Markets 1998-2007 (European Commission, Trimbos Institute, Rand Europe, 2009), p. 9.
37. P. Reuter, ‘Ten Years after the United Nations General Assembly Special Session (UNGASS): Assessing Drug Problems, Policies and Reform Proposals’, Addiction, 104, 4 (2009), 510-17.
38. L. Degenhardt, W-T. Chiu, N. Sampson, R. C. Kessler, J. C. Anthony, M. Angermeyer, R. Bruffaerts, G. de Girolamo, O. Gureje, Y. Huang, A. Karam, S. Kostyuchenko, J. P. Lepine, M. E. Medina Mora, Y. Neumark, J. H. Orme, A. Pinto-Meza, J. Posada-Villa, D. J. Stein, T. Takeshima and J. E. Wells, ‘Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine Use: Findings from the WHO World Mental Health Surveys’, PLoS Med 5(7) 2008: e141.
39. C. Reinarman, P. D. A. Cohen and H. L. Kaal, ‘The Limited Relevance of Drug Policy: Cannabis in Amsterdam and in San Francisco’, American Journal of Public Health, 94, 5 (2004), 836-42.
40. A. Wodak, ‘Tide Turns in Favour of Drug Reform’, Sydney Morning Herald, 27 August 2009.
41. A. Wodak, ‘Book Review of T. Boekhout van Solinge, Dealing with Drugs in Europe. An Investigation of European Drug Control Experiences: France, The Netherlands and Sweden, BJU Legal Publishers, The Hague, 2004’, in International Journal of Drug Policy, 17, 1 (2006) 52.
42. D. Bewley-Taylor and M. Jelsma, ‘The Internationalization of the War on Drugs: Illicit Drugs as Moral Evil and Useful Enemy’, in A. Vanaik, Selling US War s (Northampton, Massachusetts: Olive Branch Press, 2007), pp. 269-98.
43. O. R. Young, ‘The Politics of International Regime Formation: Managing Natural Resources and the Environment’, International Organization 43, 3, Summer 1989, 372.
44. O. R. Young, ‘Regime Dynamics: The Rise and Fall of International Regimes’, in S. D. Krasner, International Regimes (Ithaca, New York: Cornell University Press, 1983), pp. 106-7.
45. R. Sil and P. J. Katzenstein, Beyond Paradigms: Analytic Eclecticism in the Study of World Politics (Basingstoke, UK: Palgrave Macmillan, 2010).
46. C. Reinarman and H. G. Levine (eds.), Crack In America: Demon Drugs and Social Justice (University of California Press, 1997), p. 322.
47. M. Finnemore and K. Sikkink, ‘International Norm Dynamics and Political Change’, International Organization 52, 4 (1998), 897.
48. R. O. Keohane, After Hegemony: Cooperation and Discord in the World Political Economy (Princeton University Press, 1984), p. 103.
49. N. Christie and K. Bruun, Der Nuetzliche Feind: Die Drogenpolitik and ihre Nutzniesser (Bielefeld), Germany: AJZ Verlang, 1991.
50. J. G. March and J. P. Olsen, ‘The Institutional Dynamics of International Political Orders’, International Organization, 52, 4 (1998), 950.
51. D. Bewley-Taylor, ‘Getting High on the Policy Agenda: Europe, the US and the Future of the Global Drug Prohibition Regime’, Journal of Transatlantic Studies, 4, 1 (2006), 38-9.
52. I. L. Claude Jr., ‘Collective Legitimization as a Political Function of the United Nations’, in F. Kratochwil and E. D. Mansi eld (eds.), International Organization: A Reader (London: HarperCollins, 1994), p. 196.
53. R. Cooper, The Breaking of Nations: Order and Chaos in the Twenty-First Century (London: Atlantic Books, 2004), p. 167.
54. R. Room, ‘The Rhetoric of International Drug Control’, Substance Use and Misuse, 34, 12 (1999), 1689-707.
55. A. T. Guzman, How International Law Works: A Rational Choice Theory (New York: Oxford University Press, 2008), p. 103.
56. P. Andreas, ‘When Policies Collide: Market Reform, Market Prohibition, and the Narcotization of the Mexican Economy’ in H. R. Friman and P. Andreas (eds.), The Illicit Global Economy and State Power (Lanham, Boulder: Rowman and Littlei eld Publishers, 1999), pp. 127-8.
57. R. Keohane, Power and Governance in a Partially Globalized World (London: Routledge, 2002), p. 77.
58. P. Reuter, ‘Do No Harm: Sensible Goals for International Drug Policy’, The American Interest, Spring (March/April) 2009, 52.
59. J. Traub, The Best Intentions: Koi Annan and the UN in the Era of American Power (London: Bloomsbury, 2006).
60. M. Woodiwiss and D. Bewley-Taylor, The Global Fix: The Construction of a Global Enforcement Regime (Amsterdam: Transnational Institute, Crime and Globalization Programme, 2005), p. 16.
61. D. Manderson, From Mr Sin to Mr Big: A History of Australian Drug Laws (Oxford University Press, 1993), p. 75.
62. J. Braithwaite and P. Drahos, Global Business Regulation (Cambridge University Press, 2000), p. 397.
63. T. Babor, J. Caulkins, G. Edwards, B. Fischer, D. Foxcroft, K. Humphreys, I. Obot, J. Rehm, P. Reuter, R. Room, I. Rossow and J. Strang, Drug Policy and the Public Good (Oxford University Press, 2010), p. 206.
64. S. Rolles, After the War on Drugs: Blueprint for Regulation (Bristol, UK: Transform Drug Policy Foundation, 2009), p. 167.
65. F. Kratochwil, ‘The Force of Proscriptions’, International Organization, 38, 4 (1984), 706.
66. J. Dumbrell, ‘America in the 1990s: Searching for a Purpose’ in M. Cox and D. Stokes (eds.), US Foreign Policy (Oxford University Press, 2008), p. 89.
67. C. Prestowitz, Rogue Nation: American Unilateralism and the Failure of Good Intentions (New York: Basic Books, 2003).
68. P. Sands, Lawless World: Making and Breaking Global Rules (London: Penguin Books, 2006).
69. S. Brem and K. Stiles, Cooperating Without America: Theories and Case Studies of Non-Hegemonic Regimes (London: Routledge, 2009).
70. M. Jelsma and P. Metaal, Cracks in the Vienna Consensus: The UN Drug Control Debate (Washington, DC: Washington Office on Latin America, 2004).
71. P. M. Haas, ‘Epistemic Communities and the Dynamics of International Environmental Co-Operation’ in Rittberger, Regime Theory, p. 181.
72. E. Nadelmann, ‘Think Again. Drugs’, Foreign Policy (September-October, 2007), 26.
73. S. D. Krasner, ‘Regimes and the Limits of Realism: Regimes as Autonomous Variables’, International Organization, 36, 2 (1982), 499-500.
74. O. R. Young, International Cooperation: Building Regimes for Natural Resources and the Environment (Ithaca, New York, 1989).
75. M. Barnett and M. Finnemore, Rules for the World: International Organizations in Global Politics (Ithaca, New York: Cornell University Press, 2004), p. 2.
76. T. G. Weiss, What’s Wrong with the UN (And How to Fix it) (Cambridge: Polity Press, 2008), p. 108.
77. R. Room, ‘Trends and Issues in the International Drug Control System - Vienna 2003’, Journal of Psychoactive Drugs, 37, 4 (2005), 375.
78. A. L. Ball, ‘HIV, injecting drug use and harm reduction: a public health response’, Addiction 102 (2007), 684.
79. IHRA Briefing, What is Harm Reduction? A Position Statement from the International Harm Reduction Association (2010), www.ihra.net/iles/2010/08/10/Brieing_What_is_HR_English.pdf.
80. D. Riley and P. O’Hare, ‘Harm Reduction: History, Definition and Practice,’ in J. A. Inciardi and L. D. Harrison (eds.), Harm Reduction: National and International Perspectives (London, Thousand Oaks: Sage, 2000), p. 2.
81. C. Reinarman and H. G. Levine, ‘Real Opposition, Real Alternatives: Reducing the Harms of Drug Use and Drug Policy’, in C. Reinarman and H. G. Levine (eds.), Crack in America: Demon Drugs and Social Justice (University of California Press, 1997), p. 355.
82. T. Tammi and T. Hurme, ‘How the Harm Reduction Movement Contrasts Itself Against Punitive Prohibition’, International Journal of Drug Policy, 18, 2 (2007) 84-7.
83. L. Degenhardt, C. Hallam and D. Bewley-Taylor, Comparing the Drug Situation across Countries: Problems, Pitfalls and Possibilities (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme, Briei ng Paper 19, 2009), p. 12.
84. H. Pollack, ‘Moral, Prudential, and Political Arguments about Harm Reduction’, Contemporary Drug Problems, 35, 2-3 (2008), 214.
85. G. Roe, ‘Harm Reduction as Paradigm: Is Better than Bad Good Enough? The Origins of Harm Reduction’, Critical Public Health, 15, 3 (2005), 243-50.
86. P. G. Miller, ‘A Critical Review of Harm Minimization Ideology in Australia’, Critical Public Health, 11, 2 (2001) 173-176.
87. R. Elliott, J. Csete, E. Wood and T. Kerr, ‘Harm Reduction, HIV/AIDS, and the Human Rights Challenge to Global Drug Control Policy’, Health and Human Rights: An International Journal, 8, 2 (2005), 105-38.
88. D. Wolfe, Alchemies of Inequality: The United Nations, Illicit Drug Policy and the Global HIV Epidemic’, in K. Malinowska-Sempruch and S. Gallagher (eds.), War on Drugs, HIV/AIDS and Human Rights (New York: International Debate Education Association, 2004), pp. 158-89.
89. D. Wolfe and K. Malinowska-Sempruch, Illicit Drug Policies and the Global HIV Epidemic: Effects of UN and National Government Approaches (New York: International Harm Reduction and Development, Open Society Institute, 2004).
90. N. Hunt, M. Trace and D. Bewley-Taylor, Reducing Drug Related Harms to Health: An Overview of the Global Evidence (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme, Report 4, 2006), p. 7.
91. WHO, Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS among Injecting Drug Users (Geneva: World Health Organization, 2004), pp. 28-9.
92. A. Wodak, ‘The Current Status of Heroin Prescription Treatment for Heroin Dependence’, Expert Opinion, 4, 5 (2005), 817.
93. E. Oviedo-Joekes, S. Brissette, D. C. Marsh, P. Lauzon, D. Guh, A. Anis and M. T. Schechter, ‘Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction’, New England Journal of Medicine, 361, 8 (2009), 777-86.
94. D. Hedrich, European Report on Drug Consumption Rooms (EMCDDA, Luxembourg: Office for Official Publications of the European Communities, 2004), p. 12.
95. M. T. Aoyagi, ‘Beyond Punitive Prohibition: Liberalizing the Dialogue on International Drug Policy’, International Law and Politics, 37, 3 (2005) 555-610.
96. H. Bergeron and P. Reuter, ‘Editor’s Introduction: Policy change and policy analysis’, International Journal of Drug Policy, 20, 6 (2009) 455.
97. A. Wodak, ‘Ethics and Drug Policy’, Psychiatry 6, 2 (2007), 59.
98. E. A. Nadelmann, ‘Commonsense Drug Policy’, Foreign Affairs, 77, 1 (1998), 115.
99. International Harm Reduction Development, Harm Reduction Developments 2008; Countries with Injection-Driven HIV Epidemics (New York, Open Society Institute Public Health Programme, 2008), p. 13.
100. D. Barrett, C. Cook, R. Lines, G. Stimson and J. Bridge, Harm Reduction and Human Rights: The Global Response to Drug Related HIV Epidemics, Harm Reduction and Human Rights. A Programme of the International Harm Reduction Association (London: IHRA, 2009), p. 5.
101. T. Rosenberg, ‘The Needle Nexus’, New York Times Magazine, 17 November 2009, www.nytimes.com/2009/11/22/magazine/22FOB-idealab-t.html?_r=1.
102. I. Malkin, R. Elliott and R. McRae, ‘Supervised Injection Facilities and International Law’, Journal of Drug Issues, 33, 3 (2003), 567.
103. Wolfe, ‘Alchemies of Inequality’, in Malinowska-Sempruch and Gallagher (eds.), War on Drugs, HIV/AIDS and Human Rights, p. 172.
104. L. Utyasheva and R. Elliott, ‘Effects of UN and Russian Inl uence on Drug Policy in Central Asia’, in At What Cost? HIV and Human Rights Consequences of the Global ‘War on Drugs’ (New York: Open Society Institute Public Health Program, 2009), pp. 78-110.
105. D. Spivak, A Fourth International Convention for Drug Policy: Promoting Public Health Policies (Paris: British Institute of International and Comparative Law and the Senlis Council, 2003) pp. 17-33.
106. Malkin et al., ‘Supervised Injection Facilities and International Law’, and Legislating for Health and Human Rights: Model Law on Drug Use and HIV/AIDS (Canadian HIV/AIDS Legal Network, 2006), www.aidslaw.ca/EN/modellaw/english.htm.
107. S. K. Chatterjee, Legal Aspects of International Drug Control (The Hague: Martinus Nijhoff, 1981), pp. 356-7.
108. UN, Commentary on the Convention on Psychotropic Substances, Done in Vienna on 21 February 1971 (New York: United Nations, 1976), p. 332.
109. UN, Commentary on the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances 1988, Done at Vienna on 20 December 1988 (New York: United Nations, 1998), p. 109.
110. R. Elliott, I. Malkin and J. Gold, Establishing Safe Injection Facilities in Canada: Legal and Ethical Issues. (Montreal: Canadian HIV/AIDS Legal Network, 2002), p. 31.
111. N. Boister, Penal Aspects of the UN Drug Conventions (The Hague, London, Boston: Kluwer International, 2001), pp. 127-8.
112. N. Dorn and A. Jamieson, Room for Manoeuvre: Overview of Comparative Legal Research into National Drug Laws of France, Italy, Spain, the Netherlands, Sweden and their relation to the Three International Drug Conventions (A Study of Drugscope, London, for the Independent Inquiry on the Misuse of Drugs Act, 1971, 2000), p. 10.
113. R. Room, ‘Trends and Issues in the International Drug Control System - Vienna 2003’, Journal of Psychoactive Drugs, 37, 4 (2005), 375.
114. M. Finnemore and K. Sikkink, ‘International Norm Dynamics and Political Change’, International Organization 52, 4 (1998), 902.
115. S. Brem and K. Stiles (eds.), Cooperating Without America: Theories and Case Studies of Non-Hegemonic Regimes (London: Routledge, 2009).
116. R. J. MacCoun and P. Reuter, Drug War Heresies: Learning from Other Vices, Times & Places (Cambridge University Press, 2001), p. 13.
117. C. Chatwin, ‘Drug Policy Developments within the European Union. The Destabilizing Effects of Dutch and Swedish Drug Policies’, British Journal of Criminology, 43 (2003), 570.
118. J. Yates, ‘Sweden; A Totalitarian Threat to Europe’, International Journal of Drug Policy, 9, 4 (1998), 233-7.
119. C. Hallam, What can We Learn From Sweden’s Drug Policy Experience? (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme, Briei ng Paper 20, 2010).
120. D. R. Mares, Drug Wars and Coffeehouses: The Political Economy of the International Drug Trade (Washington, DC: CQ Press, 2006), p. 149.
121. C. Cook, J. Bridge and G. V. Stimson, ‘The Diffusion of Harm Reduction in Europe and Beyond’, in T. Rhodes and D. Hedrich (eds.), Harm Reduction: Evidence, Impacts and Challenges EMCDDA Monographs, 10 (Luxembourg: Publications Office of the European Union, 2010), pp. 37-56.
122. C. Cook and N. Kanaef, Global State of Harm Reduction 2008. Mapping the Response to Drug-Related HIV and Hepatitis C Epidemics (London: IHRA, 2008).
123. D. Boyam and P. Reuter, An Analytic Assessment of Drug Policy (Washington, DC: The AIE Press, 2005), p. 6.
124. E. Bertram, M. Blachman, K. Sharpe and P. Andreas, Drug War Politics: The Price of Denial (University of California Press, 1996), p. 34.
125. E. Nadelmann, ‘Commentary: Challenging the Global Prohibition Regime’, International Journal of Drug Policy, 9, 2 (1998), 89.
126. D. Hedrich, A. Pirona and L. Wiessing, ‘From Margin to Mainstream: The Evolution of Harm Reduction Responses to Problem Drug Use in Europe’, Drugs: Education, Prevention and Policy, 15, 6 (2008), 504.
127. G. V. Stimson and P. O’Hare, ‘Editorial: Harm Reduction: Moving Through the Third Decade’, International Journal of Drug Policy, 21, 2 (2010), 91.
128. T. Boekhout van Solinge, Dealing with Drugs in Europe. An Investigation of European Drug Control Experiences: France, the Netherlands and Sweden (The Hague: BJU Legal Publishers, 2004), p. 184.
129. WHO, The Practice and Context of Pharmacotherapy of Opioid Dependence in Central and Eastern Europe (Geneva: World Health Organization, 2004).
130. D. J. Korf and E. C. Bunning, ‘Coffee Shops, Low-Threshold Methadone and Needle Exchange: Controlling Illicit Drug Use in the Netherlands’, in Inciardi and Harrison (eds.), Harm Reduction: National and International Perspectives, pp. 125-33.
131. J. A. Inciardi and L. D. Harrison, ‘Introduction: The Concept of Harm Reduction’ in Inciardi and Harrison (eds.), Harm Reduction: National and International Perspectives, p. vii.
132. E. M. Engelsman, ‘Dutch Policy on the Management of Drug Related Problems’, British Journal of Addiction, 84, 2 (1989), 216.
133. G. A. Marlett, ‘Harm Reduction Around the World: A Brief History’, in G. A. Marlatt (ed.), Harm Reduction: Pragmatic Strategies for Managing High-Risk Behaviours (New York, London: The Guilford Press, 1998), pp. 37-41.
134. T. Makkai, ‘Harm Reduction in Australia: Politics, Policy and Public Opinion’ in Inciardi and Harrison (eds.), Harm Reduction: National and International Perspectives, pp. 171-92.
135. J-P. C. Grund, ‘Commentary. Harm Reduction in the United States at a Moment of Change: Moving Innovation from Grassroots to Mainstream’, Addiction, 104, 9 (2009) 1450-1.
136. A. Wodak, ‘Going Soft on Evidence and Due Process: Canada Adopts US Style Harm Maximization’, International Journal of Drug Policy, 19, 3 (2008), 227.
137. J. A. Silva Iulianelli, L. P. Guanabara, P. C. P. Fraga and T. Blickman, A Pointless War: Drugs and Violence in Brazil (Amsterdam: Transnational Institute, Debate Papers, 11, 2004), pp. 20-1.
138. H. L. Surratt and P. R. Telles, ‘The Harm Reduction Movement in Brazil: Issues and Experiences’, in Inciardi and Harrison (eds.), Harm Reduction: National and International Perspectives, pp. 137-53.
139. B. Nissaramanesh, M. Trace and M. Roberts, The Rise of Harm Reduction in the Islamic Republic of Iran (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme, Briefing Paper 8, 2005), p. 6.
140. H.-Z. Qian, J. E. Schumacher, H. T. Chen and Y-H. Ruan, ‘Injection Drug Use and HIV/AIDS in China: A Review of Current Situation, Prevention and Policy Implications’, Harm Reduction Journal, 3, 4 (2006), www.harmreductionjournal.com/content/pdf/1477-7517-3-4.pdf.
141. A. Trebach, The Heroin Solution (New Haven, Connecticut: Yale University Press, 1982), pp. 101-11.
142. G. Fouche, ‘Danish Addicts to get State-Funded Heroin’, The Guardian, 5 February 2009.
143. D. van der Gouwe, M. Gall à, A. van Gageldonk, E. Croes, J. Engelhardt, M. van Laar and M. Buster, Prevention and Reduction of Health-related Harm Associated with Drug Dependence: An Inventory of Policies, Evidence and Practices in the EU Relevant to the Implementation of the Council Recommendation of 18 June 2003, Synthesis Report (Utrecht: Trimbos Instituut, 2006), p. 302.
144. E. Wood and T. Kerr (eds.), ‘Cities and Drugs: Responding to Drugs in the City of Vancouver, Canada’, International Journal of Drug Policy, 17, 2 (2006), 55-141.
145. M. Hamilton, ‘Drug Policy in Australia - Our Own?’, in J. Gerber and E. L. Jensen (eds.), Drug War American Style: The Internationalization of Failed Policy and Its Alternatives (New York: Garland Publishing, 2001), p. 114.
146. A. Dowd, ‘Canada Gives More Time to Drug Injection Sites’, Reuters, 3 October 2007.
147. J. Tibbetts, ‘Tories to Shun “Safe Drug” Sites’, National Post, 23 May 2007.
148. van der Gouwe, Prevention and Reduction of Health-related Harm Associated with Drug Dependence, p. 300.
149. M. Evans and J. Buller (eds.), Policy Transfer in Global Perspective (Farnham, England: Ashgate, 2004), p. 1.
150. O. James and M. Lodge, ‘The Limitations of “Policy Transfer” and “Lesson Drawing” for Public Policy Research, Political Studies Review, 1 (2001), 179-93.
151. T. Jones and T. Newburn, ‘Learning from Uncle Sam? Exploring US Inl uences on British Crime Control Policy’, Governance, 15, 1 (2002), 104.
152. W. Parsons, Public Policy (Cheltenham, England: Edward Elgar, 1996), p. 234.
153. D. P. Dolowitz and D. Marsh, ‘Learning from Abroad: The Role of Policy Transfer in Contemporary Policy Making’, Governance, 13, 1 (2000), 6.
154. J. Boothroyd, Out of Harm’s Way: German Support for Countries in Reducing the Harm of Injecting Drug Use and HIV (Eshborn, Germany: Gesellschaft f ü r Internationale Zusammenarbeit, 2010).
155. E. J. McCann, ‘Expertise, Truth, and Urban Policy Mobilities: Global Circuits of Knowledge in the Development of Vancouver, Canada’s “Four Pillar” Drug Strategy’, Environment and Planning, A 40, 4 (2008) 885-904.
156. C. Radaelli, ‘Policy Transfer in the European Union’, Governance, 13 (2000), 6.
157. H. Bergeron and P. Grifi ths, ‘Drifting Towards a More Common Approach to a More Common Problem: Epidemiology and the Evolution of a European Drug Policy’, in R. Hughes, R. Lart and P. Higate (eds.), Drugs: Policy and Politics (London University Press, 2006), p. 113.
158. C. Chatwin, ‘Multi-level Governance: The Way Forward for European Illicit Drug Policy?’ International Journal of Drug Policy, 18, 6 (2007), 494-502.
159. S. MacGregor and M. Whiting, ‘The Development of European Drug Policy and the Place of Harm Reduction Within This’, in Rhodes and Hedrich (eds.), Harm Reduction: Evidence, Impacts and Challenges, pp. 59-77.
160. M. Elvins, Anti-Drugs Policies of the European Union. Transnational Decision-Making and the Politics of Expertise (Basingstoke, UK: Palgrave Macmillan, 2003), p. 70.
161. T. Boekhout van Solinge, Drugs and Decision-Making in the European Union (Amsterdam: Mets and Schilt Publishers, 2002), p. 23.
162. M. Jelsma, Diverging Trends in International Drug Policy Making: The Polarization Between Dogmatic and Pragmatic Approaches (Amsterdam: Transnational Institute, Drug Policy Paper, 2002), www.drugpolicy.org/docUploads/MJ_ParisSept02.pdf.
163. C. A. Birt, ‘The Onward March of European Public Health’, Journal of Epidemiology and Community Health, 52 (1998), 770-1.
164. T. Boekhout van Solinge, ‘Dutch Drug Policy in a European Context’, Journal of Drug Issues, 29, 3 (1999), 527.
165. D. Long, ‘The European Union and the Ottawa Process to Ban Landmines’, Journal of European Public Policy, 9, 3 (2002), 441.
166. M. Leonard, Why Europe will Run the 21st Century (London: Fourth Estate, 2005).
167. J. S. Nye Jr., The Paradox of American Power: Why the World’s Only Superpower Can’t Go It Alone (Oxford University Press, 2002), p. 9.
168. D. Bewley-Taylor and M. Jelsma, ‘The Internationalization of the War on Drugs: Illicit Drugs as a Moral Evil and Useful Enemy’, in A. Vanaik (ed.), Selling US Wars (Northampton, Massachusetts: Olive Branch Press, 2007), p. 294.
169. A. Kamarulzaman and S.M. Saiffuddeen, ‘Islam and Harm Reduction’, International Journal of Drug Policy, 21, 2 (2010), 117.
170. J. E. Schumacher, G. Fischer, H-Z. Qian, ‘Policy Drives Harm Reduction for Drug Abuse and HIV/AIDS Prevention in some Developing Countries’, Drug and Alcohol Dependence, 91, 2-3 (2007) 301.
171. P. Reuter and H. Pollack, ‘How Much Can Treatment Reduce National Drug Problems?’ Addiction, 101 (2006), 344.
172. S. Larney and K. Dolan, ‘Compulsory Detoxii cation is a Major Challenge to Harm Reduction in China’, International Journal of Drug Policy, 21 (2010), pp. 165-166.
173. K. DeBeck, E. Wood, T. Kerr and J. Montaner, ‘Harper’s new Anti-Drug Strategy is not anti-HIV’, National Review of Medicine, 15 September 2007.
174. A. Wodak, ‘Going Soft on Evidence and Due Process: Canada Adopts US Style Harm Maximization’, International Journal of Drug Policy, 19, 3 (2008), 226-7.
175. J.-F. Savary, C. Hallam and D. Bewley-Taylor, The Swiss Four Pillars Policy: An Evolution From Local Experimentation to Federal Law (Beckley, Oxon.: Beckley Foundation Drug Policy Programme, Briei ng Paper 18, 2009).
176. J. Csete, From the Mountaintops: What the World Can Learn from Drug Policy Change in Switzerland (New York, Open Society Foundations, Global Drug Policy Program, 2010), pp. 13-31.
177. A. Aust, Modern Treaty Law and Practice (Cambridge University Press, 2009), p. 11.
178. S. D. Krasner (ed.), International Regimes (Cornell University Press, 1983), p. 5.
179. A. Cassese, International Law, 2nd edn. (Oxford University Press, 2005), p. 196.
180. A. Macbeth, International Economic Actors and Human Rights (London: Routledge, 2010), p. 19.
181. P. S. Smith, Vienna: UN Reaffirms Prohibitionist Path. Cracks Appear in the Consensus As Clamour for Change Grows, DRCNet, 284, 25 April 2003.
182. R. Room, ‘Trends and Issues in the International Drug Control System - Vienna 2003’, Journal of Psychoactive Drugs, 37, 4 (2005), 377.
183. INCB, Report of the International Narcotics Control Board for 2003, p. 37.
184. M. T. Schechter, ‘Science, Ideology and Needle Exchange Programs’, The Annals of the American Academy of Political and Social Science, 582, 1 (2002), 94-101.
185. E. Bertram, M. Blachman, K. Sharpe and P. Andreas, Drug War Politics: The Price of Denial (University of California Press, 1996) p. 123.
186. C. Mooney, The Republican War on Science (New York: Basic Books, 2005).
187. D. Colquhoun, ‘The Highs and Lows of Policy Based Evidence’, British Medical Journal, 339, b4564 (2009).
188. J. S. Vaughn and J. D. Villalobos, ‘The Obama Administration’s Challenges after the “War on Science”: Reforming Stafi ng Practices and Protecting Scientii c Integrity in the Executive Branch’, Review of Policy Research, 26, 6 (2009), 803-4.
189. E. Wood, ‘Time for Reasoned Academic Debate on Safer Injection Facilities’, Open Medicine, www.openmedicine.ca/comment/view/128/52/6.
190. P. McKnight, ‘It isn’t Balance When Opinion Runs as Fact: A Non-Study in an Un-Journal is an Unscientii c Screed Against Vancouver’s Insite by a Drug Prohibitionist Network’, Vancouver Sun, 12 May 2007.
191. T. Blickman and D. Bewley-Taylor, The UNGASS Evaluation Process Evaluated (Witley, Surrey: International Drug Policy Consortium, Briei ng Paper, 2006), p. 3.
192. C. Carstairs. ‘The Stages of the International Drug Control System’, Drug and Alcohol Review, 24, 1 (2005), 62.
193. E. A. Nadelmann, ‘Commonsense Drug Policy’, Foreign Affairs, 77, 1 (1998), 124.
194. D. Gardener, ‘The UN’s Dirty War on Drugs: Twisting the Stats and Plating Propaganda to Cater to an American Obsession’, Ottawa Citizen, 26 April 2003.
195. F. E. Thoumi, ‘Can the United Nations support “objective” and unhampered illicit drug policy research?’ Crime, Law and Social Change 38, 2 (2002), 180.
196. R. Watson, ‘US Official Preaches Benei ts of “Drug Courts” in Curbing Misuse’, British Medical Journal, 330, 7491 (2005), 560.
197. R. I. McLaren, ‘The UN System and its Quixotic Quest for Coordination’, International Organization, 34, 1 (1980), 139-48.
198. M. Barnett and M. Finnemore, Rules for the World. International Organizations in Global Politics (Cornell University Press, 2004), pp. 40-4.
199. D. Wolfe, ‘Alchemies of Inequality: The United Nations, Illicit Drug Policy and the Global HIV Epidemic’, in K. Malinowska-Sempruch and S. Gallagher (eds.), War on Drugs, HIV/AIDS and Human Rights (New York, Amsterdam, Brussels: International Debate Education Association, 2004), p. 175.
200. D. Wolfe and K. Malinowska-Sempruch, Illicit Drug Policies and the Global HIV Epidemic: Effects of UN and National Government Approaches (International Harm Reduction and Development, Open Society Institute, New York, 2004), pp. 30-1.
201. M. Trace, D. Riley and G. Stimson, UNAIDS and the Prevention of HIV Infection Through Injecting Drug Use (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme, Briei ng Paper 9, 2005.).
202. A. Wilson, Illicit Drugs Convention Reform and the United Nations Agencies (Paris: The Senlis Council, Drug Policy Advisory Forum, 2002), p. 75.
203. C. Cook and N. Kanaef, Global State of Harm Reduction 2008. Mapping the Response to Drug-related HIV and Hepatitis C Epidemics (IHRA, 2008), p. 14.
204. M. Jelsma, The Current State of Drug Policy Debate. Trends in the Last Decade in the European Union and United Nations, 30 April 2008, www.ungassondrugs.org/index.php?option=com_content&task=view&id=206&Itemid=79.
205. D. Barrett, ‘Security, Development and Human Rights: Normative, Legal and Policy Challenges for the International Drug Control System’ International Journal of Drug Policy, 21, 2 (2010), 140.
206. D. R. Bewley-Taylor, ‘Emerging Policy Contradictions between the United Nations Drug Control System and the Core Values of the United Nations’, International Journal of Drug Policy 16, 6 (2005), 423-31.
207. E. Van Ree, ‘Drugs as a Human Right’, International Journal of Drug Policy, 10, 2 (1999), 89-98.
208. D. P. Fidler, International Law and Infectious Diseases (Oxford: Clarendon Press, 1999), pp. 197-8.
209. N. Gilmore, ‘Drug Use and Human Rights: Privacy, Disability, and Human Rights Infringements’, Journal of Contemporary Health and Law, 12, 2 (1996), 356.
210. N. Boister, Penal Aspects of the UN Drug Conventions (The Hague, London, Boston: Kluwer International, 2001) p. 524.
211. P. Hunt, ‘Confronting HIV/AIDS and Respecting Human Rights’, Open Society Institute, Protecting the Human Rights of Injection Drug Users: The Impact of HIV and AIDS (New York: International Harm Reduction and Development, Open Society Institute, 2005), p. 10.
212. T. J. Farer and F. Gaer, ‘The UN and Human Rights: At the End of the Beginning’, in A. Roberts and B. Kingsbury (eds.) United Nations: Divided World (Oxford University Press, 1993), p. 245.
213. D. Barrett and M. Nowak, ‘The United Nations and Drug Policy: Towards a Human Rights Based Approach’, in A. Constantinides and N. Zaikos (eds.), The Diversity of International Law: Essays in Honour of Professor Kalliopi K. Koufa (Leiden, the Netherlands: Brill/Martinus Nijhoff, 2009), p. 556.
214. R. Lines, The Death Penalty for Drug Offences: A Violation of Human Rights Law (Harm Reduction and Human Rights, A Programme of the International Harm Reduction Association, 2007).
215. R. Lines, ‘A ‘Most Serious Crime’? - The Death Penalty for Drug Offences and International Human Rights Law’, Amicus Journal, 21 (2010), pp. 21-8.
216. R. Elliott, I. Malkin and J. Gold, Establishing Safe Injection Facilities in Canada: Legal and Ethical Issues. (Montreal: Canadian HIV/AIDS Legal Network, 2002).
217. N. Ezard, ‘Public Health, Human Rights and the Harm Reduction Paradigm: From Risk Reduction to Vulnerability Protection’, International Journal of Drug Policy, 12, 3 (2001), 207-19.
218. N. Boister, ‘Human Rights Protections in the Suppression Conventions’, Human Rights Law Review, 2, 2 (2002), 199-227.
219. R. Elliot, J. Csete, E. Wood and T. Kerr, ‘Harm Reduction, HIV/AIDS and the Human Rights Challenge to Global Drug Control Policy’, Health and Human Rights: An International Journal, 8, 2 (2005), 104-38.
220. F. Mena and D. Hobbs, ‘Narcophobia: Drugs Prohibition and the Generation of Human Rights Abuses’, Trends in Organized Crime, 13, 1 (2009), 60-74.
221. J. Cohen, Injecting Reason: Human Rights and HIV Prevention for Injection Drug Users, California: A Case Study (New York: Human Rights Watch, 2003).
222. R. Elliot, J. Csete, E. Wood and T. Kerr, ‘Harm Reduction, HIV/AIDS, and the Human Rights Challenge to Global Drug Control Policy’, Health and Human Rights, 8, 2 (2005), 121.
223. D. Barrett, ‘Unique in International Relations’? A Comparison of the International Narcotics Control Board and the UN Human Rights Treaty Bodies (Harm Reduction and Human Rights. A Programme of the International Harm Reduction Association, 2008).
224. D. Barrett, R. Lines, R. Schleifer, R. Elliott and D. Bewley-Taylor, Recalibrating the Regime: The Need for a Human Rights-Based Approach to International Drug Policy (Beckley, Oxon., UK: The Beckley Foundation Drug Policy Programme, in partnership with the International Harm Reduction Association, Human Rights Watch and the Canadian HIV/AIDS Legal Network, Report 13, 2007), p. 1.
225. R. Room, ‘Harm Reduction, Human Rights, and the WHO Expert Committee on Drug Dependence’, in P. G. Erickson, D. Riley, Y. Cheung, P. O’Hare, Harm Reduction: A New Direction for Drug Policies and Programs (University of Toronto Press, 1997), p. 126.
226. J. Csete, ‘Rhetoric and Reality: HIV/AIDS as a Human Rights Issue’, in P. G. Harris and P. D. Siplon (eds.), The Global Politics of AIDS (Boulder, Colorado: Lynne Rienner, 2007), p. 255.
227. UNODC, World Drug Report 2008 (Vienna: United Nations, 2008), p. 9.
228. R. Kendall, ‘Cannabis Condemned: The Proscription of Indian Hemp’, Addiction, 98, 2 (2003), 143-51.
229. D. Ballotta, H. Bergeron and B. Hughes, ‘Cannabis Control in Europe’, in S. R. Sznitman, B. Olsson and R. Room (eds.), A Cannabis Reader: Global Issues and Local Experiences, EMCDDA Monographs 8, Vol. I (Luxembourg: Publications Office of the European Union, 2009), pp. 99-106.
230. K. Bruun, L. Pan and I. Rexed, The Gentlemen’s Club: International Control of Drugs and Alcohol (University of Chicago Press, 1975), pp. 181-203.
231. N. Boister, Penal Aspects of the UN Drug Conventions (The Hague, London, Boston: Kluwer International, 2001), p. 74.
232. M. Jelsma and P. Metaal, Cracks in the Vienna Consensus: The UN Drug Control Debate (Washington Office on Latin America, Drug War Monitor, January 2004), p. 12.
233. C. Walsh, ‘On the Threshold: How Relevant Should Quantity be in Determining Intent to Supply?’ International Journal of Drug Policy, 19, 6 (2008), 484.
234. T. Blickman and M. Jelsma, Drug Policy Reform in Practice: Experiences with Alternatives in Europe and the US (Amsterdam: Transnational Institute and Nueva Sociedad, 2009) p. 7, www.tni.org/paper/drug-policy-reform-practice.
235. M. Booth, Cannabis. A History (London: Doubleday, 2003), p. 225.
236. R. Room, B. Fischer, W. Hall, S. Lenton and P. Reuter, The Global Cannabis Commission Report. Cannabis Policy: Moving Beyond Stalemate (Beckley, Oxon.: The Beckley Foundation, 2008), p. 96.
237. H. Bergeron and P. Grifi ths, ‘Towards a More Common Approach to a More Common Problem: Epidemiology and the Evolution of a European Drug Policy’, in R. Hughes, R. Lart and P. Higate (eds.,) Drugs: Policy and Politics (Maidenhead, UK: Open University Press, 2006), p. 117-18.
238. R. Pacula, R. MacCoun, P. Reuter, J. Chriqui, B. Kilmer, K. Harris, L. Paoli and C. Schafer, ‘What does it Mean to Decriminalize Marijuana? A Cross-Cultural Empirical Examination’, Advances in Health Economics and Health Services Research, 16 (2005), 347-69.
239. B. de Ruyver, G. Vermeulem, T. Vander Beken, F. Vander Laenen and K. Geenens, Multidisciplinary Drug Policies and the UN Drug Treaties (Antwerpen/Apeldoorn, the Netherlands: Maklu, 2002), pp. 24-8.
240. D. McDonald, R. Moore, J. Norberry, G. Wardlaw, and N. Ballenden, Legislative Options for Cannabis in Australia (Canberra: Australian Government Publishing Service, 1994), pp. 37-69.
241. R. Room, B. Fischer, W. Hall, S. Lenton and P. Reuter, Cannabis Policy: Moving Beyond Stalemate (Beckley Oxon.: Beckley Foundation Press and Oxford University Press, 2010), pp. 78-80.
242. E. A. Voth, ‘America’s Longest War’, The World and I, February 2000.
243. J. P. Walters, ‘No Surrender: The Drug War Saves Lives’, National Review, September 27, 2004.
244. D. Bewley-Taylor, C. Hallam and R. Allen, The Incarceration of Drug Offenders: An overview (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme and King’s College London International Centre for Prison Studies, Report 16, 2009), p. 2.
245. A. DiChiara and J. F. Galliher, ‘Dissonance and Contradictions in the Origins of Marihuana Decriminalization’, Law and Society Review, 28, 1 (1994), 41-77.
246. E. Single, ‘The Impact of Marijuana Penalization: An Update’, Journal of Public Health Policy, 10, 4 (1989), 456.
247. R. Pacula, R. MacCoun, P. Reuter, J. Chriqui, B. Kilmer, K. Harris, L. Paoli and C. Schafer, What Does it Mean to Decriminalize Marijuana? A Cross-National Empirical Examination (Center for the Study of Law and Society Jurisprudence and Social Policy Program Working Paper 25, University of California, Berkeley, 2004).
248. M. Hamilton, ‘Drug Policy in Australia - Our Own?’ in J. Gerber and E. L. Jensen (eds.), Drug War American Style: The Internationalization of Failed Policy and Its Alternatives (New York: Garland Publishing, 2001), p. 111.
249. P. Webster, ‘UN Treaties and the Legalization of Drugs’, The Guardian, 28 August 2001.
250. A. Klein, ‘International Pressure, Drug Control and Political Culture: A Comparison between Jamaica and Nigeria’, African Journal of Drug and Alcohol Studies 4, 1-2 (2005), 63.
251. Barry Chevannes, ‘Criminalizing Cultural Practice: The Case of Ganja in Jamaica’, in A. Klein, M. Day and A. Harriott, Caribbean Drugs: From Criminalization to Harm Reduction (London: Zed Books, 2004), pp. 67-81.
252. H. Dellios, ‘Mexico backs off legalizing drug use’, Seattle Times, 4 May, 2006.
253. C. Moraff, ‘Latin America’s Legalization Push: As Drug Violence Rages, Mexico takes the Lead on Policy Reform’, The American Prospect, 6 July 2009, www.prospect.org/cs/articles?article=latin_americas_legalization_push.
254. E. Anderssen, ‘Would Softer Pot Law Stir the Wrath of US?’, Globe and Mail 13 July 2002, p. A5.
255. T. Blackwell, ‘Decriminalization will further Snarl the Border, US Envoy Warns’, National Post, 10 November 2004.
256. P. Reuter, ‘Do No Harm: Sensible Goals for International Drug Policy’, The American Interest, 4, 4 (2009), 47.
257. R. MacCoun, ‘American Laws, Foreign Lands. O Cannabis! Pot Decriminalization in Canada Highlights US Isolation’, San Francisco Chronicle, 11 June 2003.
258. V. Maag, ‘Decriminalization of Cannabis use in Switzerland from an International Perspective - European, American and Australian Experiences’, International Journal of Drug Policy, 14, 3 (2003), 280.
259. T. Decorte, ‘Characteristics of the cannabis market in Belgium’, in J. Fountain and D. J. Korf (eds.), Drugs in Society: European Perspectives (Oxford: Radcliffe Publishing, 2007), p. 30.
260. D. Gelders and F. Vander Laenen, ‘“Mr Police Officer, I thought Cannabis was Legal”’ - Introducing New Policy Regarding Cannabis in Belgium: A story of Good Intentions and Babel’, Drugs: Education, Prevention and Policy, 4, 2 (2007), 106.
261. M. Van Het Loo, I. Van Beusekom, and J. P. Kahan, ‘Decriminalization of Drug Use in Portugal: The Development of a Policy, Annals of the American Academy of Political and Social Science, 582, 1 (2002), 50.
262. G. Greenwald, Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies (Washington, DC: Cato Institute, 2009), p. 2.
263. C. E. Hughes and A. Stevens, ‘What Can we Learn from the Portuguese Decriminalization of Illicit Drugs’, British Journal of Criminology, 50, 6 (2010), 1003.
264. M. Van Het Loo, I. Van Beusekom, and J. P. Kahan, ‘Decriminalization of Drug Use in Portugal: The Development of a Policy’, Annals of the American Academy of Political and Social Science, 582 (2002), 54-57.
265. B. Vastag, ‘Five Years After: Portugal’s Drug Decriminalization Policy Shows Positive Results’, Scientific American, 7 April 2009, www.scientificamerican.com/article.cfm?id=portugal-drug-decriminalization.
266. D. Samuels, ‘Dr Kush: How Medical Marijuana is Transforming the Pot Industry’, The New Yorker, July 2008, www.newyorker.com/reporting/2008/07/28/080728fa_fact_samuels.
267. K. Grayson, Chasing Dragons: Security, Identity and Illicit Drugs in Canada (University of Toronto, 2008), p. 127.
268. Alison Stateman, ‘In California Marijuana Truce, a Legal Gray Area’, Time Magazine, 29 March 2009.
269. P. Katel, ‘War On Drugs: Should Nonviolent Drug Users be Subject to Arrest?’ CQ Researcher 16, 21 (2006), 495.
270. K. Vick, ‘In Calif. Medical Marijuana Laws Are Moving Pot into the Mainstream’, The Washington Post, 11 April 2009, www.washingtonpost.com/wp-dyn/content/article/2009/04/11/AR2009041100767.html.
271. E. A. Nadelmann, ‘An End to Marijuana Prohibition: The Drive to Legalize Picks Up’, National Review, July 12, 2004, 3.
272. J. F. Gamella and J. Rodrigo, ‘A Brief History of Cannabis Policies in Spain, 1968- 2003’, Journal of Drug Issues, 34, 3 (2004), 643.
273. L. Bollinger, ‘Drug Law and Policy in Germany and the European Community: Recent Developments’, Journal of Drug Issues, 34, 3 (2004), 499.
274. M. De Kort and T Cramer, ‘Pragmatism versus Ideology: Dutch Drug Policy Continued’, Journal of Drug Issues, 29, 3 (1999): 473-92.
275. J. Uitermark, ‘The Origins and Future of the Dutch Approach Towards Drugs’, Journal of Drug Issues, 34, 3 (2004), 511-33.
276. E. Leuw and I. H. Marshall (eds.), Between Prohibition and Legalization: The Dutch Experiment in Drug Policy (Amsterdam: Kugler Publications, 1994).
277. T. Boekhout van Solinge, ‘Dutch Drug Policy in a European Context’, Journal of Drug Issues, 29, 3 (1999), 511-28.
278. D. R. Mares, Drug Wars and Coffee Houses: The Political Economy of the International Drug Trade (Washington, DC: CQ Press, 2006), pp. 135-45.
279. C. F. Ruter, ‘The Basis of Dutch Policy’, in A. S. Trebach and K. B. Zeese (eds.), The Great Issues of Drug Policy (Washington, DC: Drug Policy Foundation, 1990), p. 93.
280. C. D. Kaplan, D. J. Haanraadts, H. J. Van Vliet and J. P. Grund, ‘Is Dutch Drug Policy an Example to the World?’ in Leuw and Marshal (eds.), Between Prohibition and Legalization, p. 320.
281. J. Silvas, ‘Enforcing Drug Laws in the Netherlands’, in Leuw and Marshall (eds.), Between Prohibition and Legalization, p. 49.
282. T. Boekhout van Solinge, ‘Dutch Drug Policy in a European Context’, Journal of Drug Issues, 29, 3 (1999), 517.
283. L. Zimmer and J. P Morgan, Marijuana Myths, Marijuana Facts; A Review of the Scientii c Evidence (New York: The Lindesmith Center, 1997), p. 48.
284. D. Campell, ‘Taking Flak in the Tsar Wars’, The Guardian, 28 October 1999.
285. C. W. Marris, ‘The Disasters of War: American Repression Versus Dutch Tolerance in Drug Policy’, Journal of Drug Issues 29, 3 (1999), 493-4.
286. S. Caotes, ‘US and Netherlands Reach Accord on Cutting Drug Use’, The Washington Post, 18 July 2005.
287. B. Bullington, ‘Drug Policy Reform and Its Detractors: The United States as the Elephant in the Closet’, Journal of Drug Issues, 34, 3 (2004), 701.
288. M. B. Alonso, Cannabis Social Clubs in Spain: A Normalizing Alternative Underway (Amsterdam: Transnational Institute, Federation of Cannabis Associations, Series on Legislative Reform of Drug Policies, 9, 2011).
289. C. Younger and J. Walsh, ‘Drug Decriminalization: A Trend Takes Shape’, Americas Quarterly, 2009, www.americasquarterly.org/node/977.
290. M. Charles, D. Bewley-Taylor and A. Neidpath, Drug Policy In India: Compounding Harm? (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme, Briei ng Paper 10, 2005).
291. D. Bewley-Taylor and M. Jelsma, ‘Regime Change: Re-visiting the 1961 Single Convention on Narcotic Drugs’, International Journal of Drug Policy, 23, 1 (2012), 72-81.
292. Glenn Greenwald, Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies, Cato Institute, 2009, p. 1.
293. M. Gray, Drug Crazy; How We Got into this Mess and How We Can Get Out (New York: Random House, 1998), pp. 167-8.
294. C. Reinarman, P. D. A. Cohen and H. L. Kaal, ‘The Limited Relevance of Drug Policy: Cannabis in Amsterdam and San Francisco’, American Journal of Public Health, 94, 5 (2004), 836-842.
295. L. Degenhardt, W-T. Chiu, N. Sampson, R. C. Kessler, J. C. Anthony, et al. ‘Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine Use: Findings from the WHO World Mental Health Surveys’, PLoS Med 5(7) 2008: e141.
296. L. Degenhardt, C. Hallam and D. Bewley-Taylor, Comparing the Drug Situation Across Countries: Problems, Pitfalls and Possibilities (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme, Briei ng Paper 19, 2009), p. 9.
297. D. Bewley-Taylor and C. Hallam, An Overview of Cannabis Policy: Moving Beyond Stalemate (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme, Briei ng Paper 17, 2008), p. 5.
298. E. Single, P. Christie and R. Ali, ‘The Impact of Cannabis Decriminalization in Australia and the United States’, Journal of Public Health Policy, 21, 2 (2000), 167.
299. G. Bammer, W. Hall, M. Hamilton and R. Ali, ‘Harm Minimization in a Prohibition Context’, Annals of the American Academy of Political and Social Science (2002), 582.
300. A Sutton and D. Hawks, ‘The Cannabis Infringement Notice Scheme in Western Australia: A Review of Policy, Police and Judicial Perspectives’, Drug and Alcohol Review, 24, 4 (2005), 331-6.
301. S. Lenton, ‘Pot, Politics and the Press - Rel ections on Cannabis Law Reform in Western Australia’, Drug and Alcohol Research, 23, 2 (2004), 225.
302. H. G. Levine and D. P. Small, Marijuana Arrest Crusade: Racial Bias and Police Policy in New York City, 1997-2007 (New York Civil Liberties Union, 2008), p. 7.
303. H. G. Levine, J. B. Gettman, L. Siegel, Targeting Blacks for Marijuana: Possession Arrests of African Americans in California, 2004-2008 (Los Angeles: Drug Policy Alliance, 2010).
304. M. Barnett and M. Finnemore, Rules for the World: International Organizations in Global Politics (Ithaca, New York: Cornell University Press, 2004), p. 30.
305. R. Room, ‘The Rhetoric of International Drug Control’, Substance Use and Misuse, 34, 12 (1999), 1702.
306. R. Room, ‘“Nobody Likes Coercion”: Current Themes in the International Drug Control System’, Nordisk Alkohol and Narkotikatidskrift, 19 (2002) (English Supplement), 86.
307. R. Room, ‘Trends and Issues in the International Drug Control System - Vienna 2003’, Journal of Psychoactive Drugs, 37, 4 (2005), 376.
308. INCB, Report of the International Narcotics Control Board for 2001 (New York: United Nations, 2002), p. 36.
309. N. Hunt, S. Lenton and J. Witton, Cannabis and Mental Health: Response to the Emerging Evidence (Beckley, Oxon.: Beckley Foundation Drug Policy Programme and KCA Report, 2006), p. 4.
310. Antonia Maria Costa, ‘Cannabis … Call it Anything but Soft: The Debate over the Drug is no Longer about Liberty. It’s About Health’, The Independent on Sunday, 25 March 2007.
311. WHO, WHO Expert Committee on Drug Dependence, Thirty-Fourth Report (Geneva: World Health Organization, 2006), pp. 2-3.
312. UNODC, Drug Policy and Results in Australia (Vienna: United Nations, 2008), p. 41.
313. V. Asmussen, ‘Danish Cannabis Policy in Practice: The Closing of ‘Pusher Street’ and the Cannabis Market in Copenhagen’, in Fountain and Korf (eds.), Drugs in Society, pp. 14-27.
314. B. Acevedo, ‘Creating the Cannabis User: A Post-Structuralist Analysis of the Reclassii cation of Cannabis in the UK (2004-2005)’, International Journal of Drug Policy, 18, 3 (2007), 177.
315. W. B. McAllister, Drug Diplomacy in the Twentieth Century: An International History (London: Routledge, 2000), p. 187.
316. UN, United Nations Conference for the Adoption of a Single Convention on Narcotic Drugs, New York 24 January - 25 March 1961, Official Records, Vol. I (New York: United Nations, 1964), p. 73.
317. A. Florini, ‘The End of Secrecy’, Foreign Policy, 111 (1998), 51.
318. S. Mann, ‘UN Drugs Agency Threatens Ban on $160 Million Poppy Trade’, Sydney Morning Herald, 18 December 1999.
319. N. Boister, Penal Aspects of the UN Drug Conventions (The Hague, London, Boston: Kluwer International, 2001), p. 485.
320. W. N. Gianaris, ‘The New World Order and the Need for an International Criminal Court’, Fordham International Law Journal, 16, 88 (1992), 108.
321. M. Barnett and M. Finnemore, Rules for the World: International Organizations in Global Politics (Ithaca, New York: Cornell University Press, 2004), p. 24.
322. K. Bruun, L. Pan and I. Rexed, The Gentlemen’s Club: International Control of Drugs and Alcohol (University of Chicago Press, 1975), p. 85.
323. H. Ghodse, ‘Making it Possible for Governments to do what They Say’, UN Chronicle, Summer 1998.
324. D. Small and E. Drucker, ‘Closed to Reason: Time for Accountability for the International Narcotic [sic] Control Board’, Harm Reduction Journal, 4, 2007, 13.
325. D. Bewley-Taylor and M. Trace, The International Narcotics Control Board: Watchdog or Guardian of the UN Drug Control Conventions (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme, 2006), p. 10.
326. INCB, Report of the International Narcotics Control Board for 2000 (New York: United Nations, 2001), p. 60.
327. INCB, Report of the International Narcotics Control Board for 2008 (New York: United Nations, 2009), p. 5.
328. J. Csete and D. Wolfe, ‘Progress or Backsliding on HIV and Illicit Drugs in 2008’, Lancet, 371 (2008), 1821.
329. J. Csete and D. Wolfe, Closed to Reason: The International Narcotics Control Board and HIV/AIDS (Toronto: Canadian HIV/AIDS Legal Network and the International Harm Reduction Development Program of the Open Society Institute, 2007), p. 12.
330. A. L. Taylor, ‘Addressing the Global Tragedy of Needless Pain: Rethinking the United Nations Single Convention on Narcotic Drugs’, Journal of Law, Medicine and Ethics, 35, 4 (2007) 562.
331. A. L. Taylor, L. O. Gostin and K. A. Pagonis, ‘Ensuring Effective Pain Treatment: A National and Global Perspective’, Journal of the American Medical Association, 299, 1 (2008), 89-91.
332. E. S. Hansen, ‘Safe Injection Site Breaks Treaties, UN Agency Says: Federal Health Minister Will be Urged to Shut Down Initiatives’, Vancouver Sun, 2 March 2007.
333. C. Reinarman, P. D. A. Cohen and H. L. Kaal, ‘The Limited Relevance of Drug Policy: Cannabis in Amsterdam and in San Francisco’, American Journal of Public Health, 94, 5 (2004), 836-42.
334. J. Csete, From the Mountaintops: What the World Can Learn from Drug Policy Change in Switzerland (New York: Open Society Foundation Global Drug Policy Program, 2010), pp. 22-23.
335. R. J. MacCoun and P. Reuter, Drug War Heresies: Learning from Other Vices, Times and Places (Cambridge University Press, 2001), p. 296.
336. D. Boyum and P. Reuter, An Analytic Assessment of US Drug Policy (Washington, DC: The AIE Press, 2005), pp. 74-7.
337. C. Hallam, Release Review of the INCB Annual Report for 2003 (London: Release, 2004), p. 1.
338. J. Bennetto, ‘Amsterdam Falls Out of Love with Coffee Shop as Liberal Stance on Drugs Begins to Crumble’ The Independent, 5 March 2005.
339. R. Lines, The Death Penalty for Drug Offences: A Violation of International Human Rights Law, Harm Reduction and Human Rights (London: International Harm Reduction Association, 2007).
340. R. Lemus, M. Clemencia, K. Stanton and J. Walsh, ‘Colombia: A Vicious Circle of Drugs and War’, in C. A. Youngers and E. Rosin (eds.), Drugs and Democracy in Latin America: The Impact of US Policy (Boulder, Colorado: Lynne Rienner, 2005), pp. 99-143.
341. D. Wolfe and K. Malinowska-Sempruch, Illicit Drug Policies and the Global HIV Epidemic: Effects of UN and National Government Approaches (New York: International Harm Reduction Development, Open Society Institute, 2004), p. 26.
342. D. Bewley-Taylor, ‘Emerging Policy Contradictions between the United Nations Drug Control System and the Core Values of the United Nations’, International Journal of Drug Policy, 16, 6 (2005), 425.
343. D. Bewley-Taylor, IDPC Briei ng Paper - The Need for Increased Transparency: The Country Correspondence of the International Narcotics Control Board (London: International Drug Policy Consortium, 2010), p. 5, www.idpc.net/sites/default/files/library/INCB%20Transparency%20Briei ng.pdf.
344. P. Katel, ‘War On Drugs: Should Nonviolent Drug Users be Subject to Arrest?’ CQ Researcher 16, 21 (2006), 495.
345. J. M. Pickerill and P. Chen, ‘Medical Marijuana Policy and the Virtues of Federalism’, Publius: The Journal of Federalism, 28, 1 (2008), 22-55.
346. I. Malkin, R. Elliott and R. McRae, ‘Supervised Injection Facilities and International Law’, Journal of Drug Issues, 33, 3 (2003), 564-8.
347. A. Rollins and J. Koutsoukis, ‘Labor to Push on with Heroin Trial’, The Age, 26 February 2000.
348. A. Travis, ‘High Stakes’, The Guardian, 16 April 2003.
349. A. H. Ghodse, ‘Harm Reduction: The Idea and the Ideology’, Journal of Global Drug Policy and Practice, 1, 4 (2007), www.globaldrugpolicy.org/1/4/1.php.
350. M. van Laar and M. van Ooyen-Houben (eds.), Evaluatie van het Nederlandse drugsbeleid (WODC, Den Haag, 2009).
351. F. Polak and M. Lap, ‘Response to the Report on 1992 by the INCB’, in L. Böllinger (ed.), De-Americanizing Drug-Policy: The Search for Alternatives for Failed Repression (Frankfurt am Main, Germany: Peter Lang, 1994), p. 153.
352. F. Thoumi, ‘A Modest Proposal to Clarify the Status of Coca in the United Nations Conventions’, Crime, Law and Social Change, 42, 4-5 (2004), 298.
353. D. Bewley-Taylor, The United States and International Drug Control, 1909-1997 (London: Continuum, 2001) pp. 84-9.
354. A. Henman and P. Metaal, Coca Myths (Amsterdam: Transnational Institute, Drugs and Conl ict Debate Papers, No. 17, 2009).
355. A. Regalado, ‘Bolivia Plants Coca, and Cocaine Follows’, Wall Street Journal, 18 August 2009.
356. D. Barrett, ‘Unique in International Relations’? A Comparison of the International Narcotics Control Board and the UN Human Rights Treaty Bodies (London: International Harm Reduction Association, 2008), p. 38.
357. I. Janus, Victims of Groupthink; A Psychological Study of Foreign-Policy Decisions and Fiascoes (Boston, Massachusetts: Houghton, Mifl in, 1972).
358. S. Takahashi, ‘Drug Control, Human Rights, and the Right to the Highest Attainable Standard of Health: By No Means Straightforward Issues’, Human Rights Quarterly, 31 (2009), 752-3.
359. D. Bewley-Taylor, ‘Challenging the UN Drug Control Conventions: Problems and Possibilities’, International Journal of Drug Policy, 14, 2 (2003), 174.
360. J. Koutsoukis and M. Riley, ‘Penington Slams PM Over Drugs Report’, The Age, 24 February 2000.
361. R. Room, ‘Impact and Implications of the International Drug Control Treaties on IDU and HIV/AIDS Prevention and Policy’ in J. Rehm, B. Fischer and H. Emma (eds.), Reducing the Risk, Harms and Costs of HIV/AIDS and Injection Drug Use (IDU): A Synthesis of the Evidence Base for Development Policies and Programs (Toronto: Health Canada, 2003), p. 227.
362. C. A. Kupchan, The End of the American Era: US Foreign Policy and the Geopolitics of the Twenty-First Century (New York: Vintage Books, 2003), p. 157.
363. R. Wright, ‘US has lost not 1 but 2 seats on key UN Panels’, LA Times, 8 May 2001.
364. I. Bayer, quoted in Bewley-Taylor and Trace, Watchdog or Guardian, p. 11.
365. UN, Commentary on the 1972 Protocol Amending the Single Convention on Narcotic Drugs, 1961 (New York: United Nations, 1976), p. 11.
366. F. E. Thoumi, ‘Debates recientes en las Naciones Unidas acerca del R e gimen Internacional de Control de Drogas: sus Fundamentos, Limitaciones e (Im)posibles Cambios’ in J. G. Tokatlian (ed.), Drogas y Prohibici ó n: una Vieja Guerra, Un Nuevo Debate (Buenos Aires: Libros del Zorzal, 2010), p. 46.
367. T. Gehring and S. Oberthur, ‘Expanding Regime Interaction’ in A. Underdal and O. Young (eds.), Regime Consequences: Methodological Challenges and Research Strategies (Dordrecht, the Netherlands: Kluwer Academic Publishers, 2004), p. 251.
368. R. Room and P. Rosenqvist, ‘Drugs in a Global Perspective: The International Drug Control System’s Best Foot Forward’, Addiction Research, 7, 3 (1999), 190-1.
369. O. R. Young, ‘Regime Dynamics: The Rise and Fall of International Regimes’, in S. D. Krasner (ed.), International Regimes (Ithaca, New York: Cornell University Press, 1983), p. 96.
370. P. Reuter and E. M. Truman, Chasing Dirty Money: The Fight Against Money Laundering (Washington, DC: Pearson Institute, 2004), p. 89.
371. G. Horwood, TNI Expert Seminar on the Classification of Controlled Substances (Amsterdam: Transnational Institute, 2010) p. 9, www.tni.org/iles/100304Final%20Expert%20Seminar%20Report.pdf.
372. W. B. McAllister, Drug Diplomacy in the Twentieth Century: An International History (London: Routledge, 2000), pp. 230-4.
373. M. Jelsma, Legislative Innovation in Drug Policy, Latin American Initiative on Drugs and Democracy, October 2009, pp. 16-17.
374. R. Room, B. Fischer, W. Hall, S. Lenton and P. Reuter, Cannabis Policy: Moving Beyond Stalemate (Beckley Foundation Press and Oxford University Press, 2010), p. vi.
375. M. Leinwand, ‘The International Law of Treaties and United States Legalization of Marijuana’, Columbia Journal of Transatlantic Law, 10, 2 (1971), 43.
376. D. Bewley-Taylor and M. Jelsma, Fifty Years of the 1961 Single Convention on Narcotic Drugs: A Reinterpretation (Amsterdam: Transnational Institute, Series on Legislative Reform of Drug Policies, 12, 2011), p. 11.
377. D. Nutt, L. A. King, W. Saulsbury and C. Blakemore, ‘Development of a rational scale to assess the harm of drugs of potential misuse’, The Lancet, 369, 9566 (2007) 1047-53.
378. M. Kleiman, Against Excess: Drug Policy for Results (New York: Basic Books, 1992), p. 7.
379. K. Shibuya, C. Ciecierski, E. Guindon, D. W. Bettcher, D. B. Evans and C. J. L. Murray, ‘WHO Framework Convention on Tobacco Control: Development of an Evidence Based Global Public Health Treaty’, British Medical Journal, 327 (2003), 154-7.
380. K. Bruun, L. Pan and I. Rexed, The Gentlemen’s Club: International Control of Drugs and Alcohol (University of Chicago Press, 1975), p. 180.
381. P. Andreas and E. Nadelmann, Policing the Globe: Criminalization and Crime Control in International Relations (Oxford University Press, 2006), p. 45.
382. A. Henman and P. Metaal, Coca Myths (Amsterdam: Transnational Institute, Drugs and Conl ict Debate Paper, No. 17, 2009), p. 9.
383. M. Jelsma, The Current State of Drug Policy Debate: Trends in the Last Decade in the European Union and United Nations (Support text for the i rst meeting of the Latin American Commission on Drugs and Democracy, Rio de Janeiro, 2008), p. 15, www.ungassondrugs.org/images/stories/currentstate-e.pdf.
384. E. Bertram, M. Blachman, K. Sharpe and P. Andreas, Drug War Politics: The Price of Denial (University of California Press, 1996).
385. E. Wood, D. Werb, B. D. L. Marshall, J. S. G. Mortimer and T. Kerr, ‘The War on Drugs: A Devastating Public Policy Disaster’, The Lancet, 373 (2009), 989.
386. D. Barrett, ‘Security, Development and Human Rights: Normative, Legal and Policy Challenges for the International Drug Control System’, International Journal of Drug Policy, 21, 2 (2010), 141.
387. D. Werb, G. Rowell, G. Guyatt, T. Kerr, J. Montaner and E. Wood, Effect of Drug Law Enforcement on Drug Related Violence: Evidence from a Scientii c Review (Vancouver: International Centre for Science in Drug Policy, 2010), p. 7.
388. M Meyer, C. Youngers and D. Bewley-Taylor, At a Crossroads: Drug Trafficking, Violence and the Mexican State (Beckley, Oxon.: Washington Office on Latin America and The Beckley Foundation Drug Policy Programme, Briei ng Paper 13, 2007), p. 1, www.beckleyfoundation.org/pdf/Briei ngPaper13.pdf.
389. D. Bewley-Taylor, C. Hallam and R. Allan, The Incarceration of Drug Offenders: An Overview (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme and International Centre for Prison Studies, King’s College London, University of London, Report 16, 2009), www.beckleyfoundation.org/pdf/BF_Report_16.pdf.
390. P. Metaal and C. Youngers (eds.), Systems Overload: Drug Laws and Prisons in Latin America (Amsterdam and Washington, DC: Washington Office on Latin America and Transnational Institute, 2011).
391. A. Klein, M. Roberts and M. Trace, Drug Policy and the HIV Pandemic in Russia and the Ukraine (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme. A Drugscope Briei ng Paper, 2, 2004), p. 3.
392. D. Barrett, R. Lines, R. Schleifer, R. Elliott and D. Bewley-Taylor, Recalibrating the Regime: The Need for a Human Rights-Based Approach to International Drug Policy (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme, in partnership with the International Harm Reduction Association, Human Rights Watch and the Canadian HIV/AIDS Legal Network, Report 13, 2007).
393. F. Mena and D. Hobbs, ‘Narcophobia: Drugs Prohibition and the Generation of Human Rights Abuses’, Trends in Organized Crime, 13, 1 (2009), 60-74.
394. J. Donnelly, Universal Human Rights in Theory and Practice (Ithaca, New York: Cornell University Press 2003), p. 129.
395. M. C. R. Lemus, K. Stanton and J. Walsh, ‘Colombia: A Vicious Circle of Drugs and War’, in C. A. Youngers and E. Rosin (eds), Drugs and Democracy in Latin America: The Impact of US Policy (Boulder, Colorado: Lynne Reinner Publishers, 2005) pp. 99-142.
396. D. Bewley-Taylor, The United States and International Drug Control, 1909-1997 (London: Continuum, 2001), p. 186.
397. J. Braithwaite and P. Drahos, Global Business Regulation (Cambridge University Press, 2000), p. 397.
398. D. Manderson, From Mr Sin to Mr Big: A History of Australian Drug Laws (Oxford University Press, 1993), p. 75.
399. C. J. S. Fazey and D. Bewley-Taylor, ‘Prohibition, Pragmatism and Drug Policy Repatriation’, International Journal of Drug Policy, 14, 2 (2003), 142.
400. M. Jelsma and P. Metaal, Cracks in the Vienna Consensus: The UN Drug Control Debate (Washington, DC: Washington Office on Latin America, 2004), p. 21.
401. T. Blickman and M. Jelsma, Drug Policy Reform in Practice: Experiences with Alternatives in Europe and the US (Amsterdam: Transnational Institute and Nueva Sociedad, 2009), pp. 14-15.
402. A. Wodak, ‘All Drug Politics is Local’, International Journal of Drug Policy, 17, 2 (2006), 84.
403. O. R. Young, ‘Regime Dynamics: The Rise and Fall of International Regimes’, in S. D. Krasner (ed.), International Regimes (Ithaca, New York: Cornell University Press, 1983), p. 108.
404. P. Wintour, ‘Shift in treatment of drug addicts to focus on live-in schemes’, The Guardian, 7 August 2010.
405. D. R. Bewley-Taylor, ‘Harm Reduction and the Global Drug Control Regime: Contemporary Problems and Future Prospects’, Drug and Alcohol Review 23, 4 (2004), 488.
406. D. P. Fidler, ‘The Globalization of Public Health: The First 100 Years of International Health Diplomacy’, Bulletin of the World Health Organization, 79, 9 (2001) 844-6.
407. G. Papandreou, ‘Aims and Priorities of the Greek EU-Presidency’, Eleftherotypia, 25 November 2002.
408. M. Trace, ‘The Global Drug Charade: Flying in the Face of all Evidence, the UN is about to Recommit to the Tried and Failed Approach’, The Guardian, 11 March 2009.
409. A. Dom inguez, ‘Steady Course, Winds of Change’ Comunidade Segura (Brazil) 20 March 2009, www.comunidadesegura.org/en/STORY-steady-course-winds-of-change.
410. D. Bewley-Taylor, ‘The 2009 Commission on Narcotic Drugs and its High Level Segment: More Cracks in the Vienna Consensus’, Drugs and Alcohol Today, 9, 2 (2009), 10.
411. D. R. Bewley-Taylor, ‘Challenging the UN Drug Control Conventions: Problems and Possibilities’, International Journal of Drug Policy, 14, 2 (2003), 171-9.
412. S. Rolles, After the War on Drugs: Blueprint for Regulation (Bristol, UK: Transform Drug Policy Foundation, 2009), pp. 165-91.
413. L. R. Helfer, ‘Exiting Treaties’, Virginia Law Review, 91, 7 (2005), 1602.
414. Coletta A. Youngers, The Obama Administration’s Drug Control Policy on Auto-Pilot (London: International Drug Policy Consortium, Briei ng Paper, 2011).
415. C. A. Kupchan, The End of the American Era: US Foreign Policy and the Geopolitics of the Twenty-First Century (New York: Vintage Books, 2003), p. 3.
416. R. Cooper, The Breaking of Nations: Order and Chaos in the Twenty-First Century (London: Atlantic Books, 2004), p. 173.
417. D. Bewley-Taylor, ‘Emerging Policy Contradictions between the United Nations Drug Control System and the Core Values of the United Nations’, International Journal of Drug Policy, 16, 6 (2005), 427.
418. R. MacCoun and P. Reuter, Drug War Heresies: Learning from Other Vices, Times & Places (Cambridge University Press, 2001), p. 308.
419. D. Snidal, ‘The Limits of Hegemonic Stability Theory’, International Organization, 39, 4 (1985), 579-614.
420. J. Buxton, The Political Economy of Narcotics: Production, Consumption and Global Markets (London: Zed Books, 2006), p. 211.
421. B. Cronin, ‘The Paradox of Hegemony: America’s Ambiguous Relationship with the United Nations’, European Journal of International Relations, 7, 1 (2001), 103-30.
422. S. Haseler, Super-State: The New Europe and Its Challenge to America (London: I.B. Tauris, 2004), p. viii.
423. O. Harries, ‘The Collapse of the West’, Foreign Affairs 72, 4 (1993), 41-9.
424. N. Ferguson, ‘Three Reasons Why the US and Europe Won’t Make Up’, The Guardian, 21 February 2005.
425. C. Reinarman, ‘Geo-political and Cultural Constraints on International Drug Control Treaties’, International Journal of Drug Policy, 14, 2 (2003), 206.
426. F. Thoumi and E. Jensema, ‘Drug policies and the Funding of the United Nations Office on Drugs and Crime’, in Global Drug Policy: Building a New Framework (Paris: The Senlis Council, 2003), pp. 32-9.
427. D. Bewley-Taylor and M. Trace, The Funding of the United Nations Office on Drugs and Crime; An Uni nished Jigsaw (Beckley, Oxon.: The Beckley Foundation Drug Policy Programme, Report 11, 2006), p. 12, www.beckleyfoundation.org/pdf/Beckley_Report11.pdf.
428. R. N. Haass, ‘The Age of Nonpolarity: What will Follow US Dominance’, Foreign Affairs 87, 3 (2008), 44-56.
429. T. S. Mowle, Allies at Odds? The United States and the European Union (Basingstoke, UK: Palgrave Macmillan, 2004), p. 25.
430. B. Bullington, L. B o llenger and T. Shelly, ‘Trends in European Drug Policies: A New Beginning or More of the Same?’ Journal of Drug Issues, 34, 3 (2004), 481.
431. P. Toynbee, ‘In the War on Drugs, Europe Must Make a Separate Peace’, The Guardian, 3 November 2004.
432. J. Zielonka, Explaining Euro-Paralysis: Why Europe Is Unable to Act in International Politics (Basingstoke, UK: Palgrave, 1998), p. 3.
433. K. Smith, European Foreign Policy in a Changing World (Cambridge, UK: Polity, 2008), p. 2.
434. R. Gowan and F. Brantner, The EU and Human Rights at the UN - 2009 Review (London: European Council on Foreign Relations, September 2009), www.ecfr.eu/content/entry/un_2009_annual_review_gowan_page.
435. C. Youngers, ‘Beyond the Drug War’, Foreign Policy In Focus, www.fpif.org/articles/beyond_the_drug_war.
436. C. Youngers and J. Walsh, ‘Drug Decriminalization: A Trend Takes Shape’, Americas Quarterly, www.americasquarterly.org/print/978.
437. M. Jelsma, Lifting the Ban on Coca Chewing: Bolivia’s Proposal to Amend the 1961 Single Convention (Amsterdam: Transnational Institute, Series on Legislative Reform of Drug Policies, No. 11, March 2011), pp. 5-6.
438. Y. Fedotov, Director-General/Executive Director, ‘A New Strategy and New Partnerships for Drug Control’, Commission on Narcotic Drugs, Fifty-Fourth Session, Vienna, 21 March 2011, www.unodc.org/unodc/en/about-unodc/speeches/2011/March/2011-03-21-cnd-opening-session.html.